¿ÆÑ§¼Ò¹¹½¨ÅßÍâÖÐÅß²ãÌåÍâ·¢ÓýÄ£×Ó ÈÕÆÚ£º2022-09-29 À´Àú£º±¾Õ¾ ¹©¸å£º¹æ»®Ðµ÷´¦ ×÷ÕߣºÖÎÀíÔ± ÖÖ±ð£ºÒëÎÄ
ÈËÀàÅßÌ¥·¢ÓýÓÚ×Ó¹¬ÄÚ¾ÙÐУ¬ÊÇÒÔÈËÃǶÔÓÚÔÚÖ²ÈëºóµÄÈËÀàÅßÌ¥»¹ÓÐÖªÖ®ÉõÉÙ¡£ÏëÒª¾ÙÐÐÈËÀàÅßÌ¥·¢ÓýÑо¿£¬182ÌåÓý¹ÙÍø-ÐèÒª¶ÔÓÚÈËÀàÅßÌ¥ÍâÖÐÅß²ãϸ°û·Ö½âÀú³Ì¾ÙÐÐÀí½â¡£ ½üÈÕ£¬·¢±íÓÚ¡¶Cell Stem Cell¡·ÉϵÄÒ»ÏîÌâΪ¡°Modeling human extraembryonic mesoderm cells usingnaive pluripotent stem cells¡±µÄÑо¿ÖУ¬±ÈÀûʱ³ãëÄêҹѧÑо¿Ö°Ô±Ê¹ÓÃÔʼ̬ÈËÀà¶àÄܸÉϸ°û³ÉÁ¢ÁËÄ£·ÂÈËÀàÅßÍâÖÐÅß²ãµÄ³õÆÚ·¢ÉúÀú³ÌµÄÄ£×Ó¡£ Ñо¿Ö°Ô±¶ÔÓÚÒýÓÕ30ÌìµÄ¶àÄܸÉϸ°û¾ÙÐе¥»ùÒò²âÐò£¬¾Óɹý³Ì²âÐò³É¹û±È¶ÔÓÚ²û·¢£¬ÈÏΪ»ñµÃÁËÅßÌ¥ÍâÖÐÅß²ãϸ°û£¨EXMCs£©£¬½øÒ»²½²û·¢·¢Ã÷ÌåÍâEXMCs¿ÉÒÔ»òÐí¹éÄÉ×ÛºÏÈËÀàÒÔºÍɽ¹«ÅßÌ¥Ö²Èë¶ùÅ®»ùÒò±í´ïÆ×£¬ÊµÏÖÉÏÆ¤µ½¼ä³äÖʵÄת»¯¡£¸ÃÑо¿»¹Óз¢Ã÷¹ÇËè»ùÖÊ¿¹Ô2£¨BST2£©¿ÉÒÔ×÷ΪEXMCsµÄÍâò±ê¼ÇÎ¾Óɹý³Ìµ¥Ï¸°ûµ÷¿ØÍøÂ·×ÌÈÅÒԺ;ÛÀà²û·¢µÄ·½Ê½¶ÔÓÚEXMCsÖеĻùÒòµ÷¿ØÊÕ¼¯¡¢µ¥Ï¸°ûȾɫÖʿɺÍÐÔ¾ÙÐÐÁ˽ç˵¡£ ¸ÃÄ£×Ó°ïæÈËÀàÀí½â×Å´²ÆÚ¼äÖÜΧÅßÌ¥·¢ÉúÀú³ÌÖÐϸ°ûÔËÆøÌØ»¯µÄÊÂÎñ£¬Ò²Îª·¢ÓýȱÏݵȲ¡ÀíÐÔÑо¿ÌṩÁËÌåÍâ²Ù×÷Ä£×Ó¡£ ÂÛÎÄÁ´½Ó£ºhttps://www.cell.com/cell-stem-cell/fulltext/S1934-5909(22)00337-X?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS193459092200337X%3Fshowall%3Dtrue ×¢£º´ËÑо¿½á¹ûÕª×Ô¡¶Cell Stem Cell¡·£¬ÎÄÕÂÄÚÈݲ»´ú±í±¾ÍøÕ¾²»Ñŵ㼰̬¶È£¬½ö¹©²Î¿¼¡£-182ÌåÓý¹ÙÍø-